Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
After finishing at $2.20 in the prior trading day, Perspective Therapeutics Inc (AMEX: CATX) closed at $2.13, down -3.18%. In other words, the price has decreased by -$3.18 from its previous closing price. On the day, 0.98 million shares were traded. CATX stock price reached its highest trading level at $2.2 during the session, while it also had its lowest trading level at $2.01.
Ratios:
Our goal is to gain a better understanding of CATX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.68 and its Current Ratio is at 12.68. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on March 13, 2025, initiated with a Buy rating and assigned the stock a target price of $10.
On March 07, 2025, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $15.
BofA Securities Downgraded its Buy to Neutral on November 25, 2024, whereas the target price for the stock was revised from $24 to $5.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 04 ’24 when HENSON HEIDI bought 25,975 shares for $3.85 per share. The transaction valued at 100,004 led to the insider holds 25,975 shares of the business.
Spoor Johan M. bought 8,000 shares of CATX for $30,132 on Dec 04 ’24. The CEO now owns 36,257 shares after completing the transaction at $3.77 per share. On Nov 25 ’24, another insider, Williamson Robert F III, who serves as the Director of the company, bought 6,266 shares for $3.64 each. As a result, the insider paid 22,814 and bolstered with 430,058 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CATX now has a Market Capitalization of 162914128 and an Enterprise Value of -65123580. For the stock, the TTM Price-to-Sale (P/S) ratio is 108.78 while its Price-to-Book (P/B) ratio in mrq is 0.52. Its current Enterprise Value per Revenue stands at -44.789 whereas that against EBITDA is 1.01.
Stock Price History:
The Beta on a monthly basis for CATX is 1.20, which has changed by -0.8541096 over the last 52 weeks, in comparison to a change of 0.077997446 over the same period for the S&P500. Over the past 52 weeks, CATX has reached a high of $19.05, while it has fallen to a 52-week low of $2.19. The 50-Day Moving Average of the stock is -27.02%, while the 200-Day Moving Average is calculated to be -74.67%.
Shares Statistics:
The stock has traded on average 778.10K shares per day over the past 3-months and 662410 shares per day over the last 10 days, according to various share statistics. A total of 70.67M shares are outstanding, with a floating share count of 53.97M. Insiders hold about 27.12% of the company’s shares, while institutions hold 68.21% stake in the company. Shares short for CATX as of 1741910400 were 5939698 with a Short Ratio of 7.63, compared to 1739491200 on 5480817. Therefore, it implies a Short% of Shares Outstanding of 5939698 and a Short% of Float of 10.7.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
